Treating Patients With Childhood Acute Myeloid Leukemia With Interleukin-2

PHASE3UnknownINTERVENTIONAL

Enrollment

580

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

December 31, 2010

Study Completion Date

March 31, 2012

Conditions

Leukemia

Interventions

DRUG

proleukin

"One cycle of treatment : D1 : 2.5 MUI/m2 (subcutaneous); D2 to D5 : 5 MUI / m2 (subcutaneous)~1 cycle of treatment each month during 12 months"

Trial Locations (1)

RECRUITING

Children Armand Trousseau Hospital, Paris